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Abstract  19 
We previously showed that single amino acid substitutions at seven positions 20 
in hemagglutinin determined major antigenic change of influenza H3N2 virus. 21 
Here, the impact of two such substitutions was tested in eleven representative 22 
H3 hemagglutinins to investigate context-dependence effects. The antigenic 23 
effect of substitutions introduced at hemagglutinin position 145 was fully 24 
independent of the amino acid context of the representative hemagglutinins. 25 
Antigenic change caused by substitutions introduced at hemagglutinin position 26 
155 was variable and context-dependent. Our results suggest that epistatic 27 
interactions with contextual amino acids in the hemagglutinin can moderate the 28 
magnitude of antigenic change.  29 
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Influenza viruses of the H3N2 subtype have been circulating in humans since 30 
1968 and are a major cause of annual epidemics. Antibodies against the 31 
hemagglutinin (HA) surface glycoprotein can neutralize the virus and are a 32 
critical component of our immune defense against influenza viruses. However, 33 
the HA changes over time to escape from recognition by neutralizing antibodies 34 
present in the human population. The antigenic evolution of H3N2 viruses was 35 
previously mapped using hemagglutination inhibition (HI) assay data spanning 36 
a 35-year period (1). During this period, 11 genetically and antigenically distinct 37 
clusters emerged that comprise viruses of high antigenic similarity, each of 38 
which was consecutively replaced by a new cluster of antigenically distinct 39 
viruses (Fig 1A). Antigenic cluster transitions, the major antigenic changes 40 
between clusters, were subsequently shown to be predominantly caused by 41 
single amino acid substitutions on seven key positions adjacent to the HA 42 
receptor binding site (RBS) (2). Most positions were involved in cluster 43 
transitions multiple times suggesting that possibilities for antigenic change of 44 
influenza viruses are restricted (Fig. 1B and 1C).  45 
 46 
Epistatic interactions can shape the evolution of influenza viruses (3–6). For 47 
example, intragenic epistasis in HA has been suggested to limit the rate of 48 
antigenic evolution and to inhibit the reversal of RBS substitutions to ancestral 49 
genotypes (5–8). An important question that remains unanswered is whether 50 
the HA amino acid context in which a substitution occurs determines its ability 51 
to escape from antibody recognition. 52 
 53 
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To answer this question, we selected two substitutions that were responsible 54 
for major antigenic change during H3N2 virus antigenic evolution (Fig. 1B). 55 
Substitution 155TY was responsible for the first antigenic cluster transition of 56 
the H3N2 virus in 1972, and 155YH together with 159SY and 189KR caused 57 
an antigenic cluster transition in 1987 (2). Substitution 145NK first caused an 58 
antigenic cluster transition in 1989 after 21 years of H3N2 virus evolution in 59 
humans (1, 2). The same substitution was responsible for another cluster 60 
transition six years later. We introduced the substitutions as single mutations 61 
into the HA genes of viruses representing the 11 antigenic clusters (Fig. 1D). 62 
Depending on the amino acid at position 155 or 145, we introduced either 155Y 63 
or T, or 145K or N in the HA genes (Fig. 1D). Viruses with naturally occurring 64 
145SN substitutions were detected from 1973 onwards (1). Between 1975 and 65 
1989 nearly all isolated strains had 145N. However, the 145SN substitution did 66 
not contribute to major antigenic change during this period (2). When 67 
representative viruses had 145S we therefore introduced 145K, but not 145N. 68 
Substitution 155H was involved in the cluster transition that occurred in 1987 69 
and 155H remained dominant between 1987 and 2002. For representative 70 
viruses with 155H, two modified HA genes containing either 155T or 155Y were 71 
constructed (Fig 1D). All introduced substitutions resulted in substantial 72 
changes in the biophysical properties of the amino acids. Plasmids containing 73 
wildtype or modified HA genes were used to generate recombinant viruses 74 
consisting of the (modified) HA gene and remaining genes of A/Puerto 75 
Rico/8/34 by reverse genetics  (9). The presence of introduced mutations and 76 
absence of unwanted changes in HA was confirmed by Sanger sequencing. 77 
Subsequently, the antigenic properties of recombinant viruses were analyzed 78 
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in HI assays using the previously defined panel of ferret antisera listed in Table 79 
S1 (2, 10). To test the antigenic difference between 155T and 155Y in 80 
representative viruses with 155H we compared the HI results of the 155T and 81 
155Y mutants. 82 
 83 
Mutants with substitutions at HA position 155 in HK68, EN72, VI75, TX77, 84 
SY97, and FU02 representative viruses were substantially antigenically 85 
different from their respective wildtype viruses, with up to 64-fold differences in 86 
HI titers (Fig. 2A). The 155TY amino acid difference at position 155 had a small 87 
antigenic effect in the HA context of all but one of the remaining representative 88 
viruses (SI87, BE89, BE92, WU95). Additionally, substitutions 155HT and HY 89 
had no or only modest antigenic effects in these four representative viruses— 90 
none had a more than 2-fold HI titer reduction against sera raised to viruses 91 
with homologous wildtype HAs. In the SY97 HA the 155T mutant was 92 
substantially antigenically different from the wildtype virus, but the 155Y mutant 93 
was not. Of the five representative viruses with a naturally present 155H, the 94 
155TY amino acid difference thus had a substantial antigenic effect only in the 95 
context of a single HA. These data strongly suggest that the modest effect of 96 
the 155TY difference in multiple HAs was due to the amino acid context in which 97 
it was introduced. Thus, although the TY substitution at position 155 98 
substantially changed the antigenic properties in more than half of the HAs 99 
tested here, the HA amino acid context in which this substitution occurs may 100 
dampen its ability to escape from antibody recognition. 101 
 102 
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In contrast, mutants with substitutions on position 145 of the same set of 103 
representative HAs were each antigenically distinct from their respective 104 
wildtype viruses (Fig. 2B). Thus, the magnitude of antigenic change caused by 105 
145 NK or KN substitutions appears not to be affected by the HA amino acid 106 
context. 107 
 108 
Substitution 145NK was first observed when it caused the antigenic cluster 109 
transition from the SI87 to the BE89 cluster (Fig. 1A and 1B). When 145K was 110 
introduced in the HA of viruses representing the antigenic clusters that 111 
circulated prior to the SI87 cluster (HK68, EN72, VI75, TX77, and BK79), it 112 
caused similar escape from inhibition by antisera to contemporary or previously 113 
circulating strains as did 145K in the SI87 representative virus (Fig. 2B). We 114 
therefore next compared the magnitude of antigenic escape by 145K to that of 115 
the cluster-transition substitutions that occurred naturally before 1989 (Fig. 1). 116 
In this analysis, only antisera to strains from the same or previous antigenic 117 
clusters as the representative virus were included, thus testing escape from 118 
antibodies induced to previously circulating strains. The magnitude of the 119 
antigenic differences caused by 145K were similar to those caused by the 120 
naturally occurring substitutions that were responsible for antigenic cluster 121 
transitions before 1989 (Fig. 2C). Thus, if viruses with 145K had appeared 122 
before the BE89 antigenic cluster they may have been sufficiently antigenically 123 
different from earlier H3N2 viruses to provide escape from population immunity. 124 
 125 
The central question addressed in this study was if the antigenic effect of 126 
substitutions in HA is dependent on the amino acid context in which they occur. 127 
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We answered this question using two substitutions known to be responsible for 128 
escape from population immunity in the past and the same analysis methods 129 
that were used to determine the contribution of these substitutions to antigenic 130 
evolution (2). The data generated for this study reflect the ability of the test 131 
viruses to escape from binding by antibodies in polyclonal ferret antisera at a 132 
fixed HA-activity. The magnitude of antigenic change caused by the introduced 133 
substitutions in the representative hemagglutinins far exceeds the antigenic 134 
change observed in studies using hemagglutinins with different binding avidities 135 
(11-13). Additionally, the large titer differences observed between sera tested 136 
to the same virus, up to 6.8 log2 HI titer differences between sera, suggest that 137 
our results are not simply a reflection of the small differences that are the 138 
resultant of variations in receptor avidity. 139 
 140 
HA amino acid context did not affect the magnitude of antigenic change caused 141 
by substitutions introduced on position 145, nor of the majority of substitutions 142 
introduced at position 155. Thus, the ability to cause antibody escape in the 143 
HAs tested here was largely independent of the amino acid context. While these 144 
results are in agreement with the recurrent use of seven key positions for major 145 
antigenic change during influenza H3N2 virus evolution and emphasize the 146 
potential importance of these key positions for future antigenic change (2), the 147 
data also suggest that epistatic interactions govern the antigenic effect caused 148 
by the substitutions introduced HA position 155. 149 
 150 
The differences in magnitude of the antigenic effects of 155T and 155Y 151 
substitutions versus the context-independent antigenic changes caused by the 152 
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145N and 145K substitutions in different amino acid backgrounds may be due 153 
to differences in local HA structure (Fig. 3). Position 155 is located in the 154 
depression between the 190-helix that contains conserved position 195Y and 155 
a loop that contains conserved position 153W, which are fundamental 156 
components of the RBS (14, 15). In contrast, position 145 is located on a 157 
protruding loop that may have fewer structural constraints. Therefore, the 158 
substitutions introduced at position 145 may possibly have a larger impact on 159 
the local HA structure than the substitutions introduced at position 155, resulting 160 
in the more pronounced antigenic changes in the mutants with a substitution at 161 
position 145 observed here. 162 
 163 
The ability of a new antigenic variant to escape from population immunity 164 
depends on the distance between the antigenic variant and the contemporary 165 
epidemic virus, which should be sufficiently large to escape from neutralization 166 
by antibodies to currently circulating viruses. Additionally, the direction of 167 
antigenic evolution should be away from all previously circulating viruses to 168 
maximize escape from recognition by antibodies to viruses responsible for 169 
earlier epidemics. We have here focused on testing the magnitude of antigenic 170 
change caused by substitutions in different HA amino acid contexts because 171 
limitations inherent to our experimental setup preclude meaningful analysis of 172 
directionality. Although our data indicate that the magnitude of antigenic change 173 
by 145K in HAs representative of early evolution strains equals that of the 174 
naturally selected escape mutants, we can make no claims about the 175 
directionality of antigenic change. Earlier work showed that epistatic 176 
interactions can affect the directionality of antigenic evolution because 177 
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introduction of co-occurring mutations with cluster-transition substitutions 178 
changed the directionality of the mutant viruses without adding to the antigenic 179 
distance (2). Although many evolutionary variables may determine which 180 
viruses eventually cause an epidemic, viruses with naturally selected escape 181 
mutations perhaps had a more favorable direction of antigenic evolution 182 
compared to viruses with 145K in HAs prior to 1989, which could explain why 183 
145K escape mutants did not emerge during the first decades of H3N2 virus 184 
evolution. 185 
 186 
In summary, the requirement that substitutions occur in an HA context that is 187 
permissive for the protein changes that induce antibody escape suggests that 188 
the magnitude of antigenic change depends on epistatic interactions. 189 
Understanding the role of epistasis in antigenic evolution will help to evaluate 190 
the epidemic potential of newly emerging viruses.  191 
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FIG 1 Experimental background and viruses used in this study. (A) Antigenic 
map of H3N2 virus antigenic evolution between 1968 and 2003. Open squares 
and colored circles indicate antisera and epidemic viruses, respectively. The 
viruses are color coded according to the antigenic cluster cluster to which the 
virus belongs. Both horizontal and vertical axes indicate antigenic distance, the 
spacing between gridlines is one antigenic unit which equals a two-fold 
difference in the HI assay. Letters and digits in antigenic cluster names refer 
to the location and year of isolation of the first vaccine strain in that cluster 
(HK, Hong Kong; EN, England; VI, Victoria; TX, Texas; BK, Bangkok; SI, 
Sichuan; BE, Beijing; WU, Wuhan; SY, Sydney; FU, Fujian). The large circles 
indicate the viruses used in this study to represent the antigenic cluster clusters. 
(B) Substitutions responsible for antigenic cluster transitions as defined in (2). 
(C) Amino acid positions responsible for major antigenic change during H3N2 
virus antigenic evolution plotted on an A/Aichi/2/68 HA trimer (PDB accession 
code 5HMG). Monomers are shown in black, grey, and white, while the RBS is 
in yellow. Amino acid positions 145 and 155 are indicated in red and blue, 
respectively, while the remaining key positions are indicated in orange. (D) 
Mutants constructed for this study. Cluster representative viruses had the HA 
amino acid consensus sequence of all viruses in that cluster (described in (2)). 
BI, Bilthoven; NL, The Netherlands. 
 
FIG 2 (A) HI titer differences between viruses with wild type and 155 mutant 
HAs. Each symbol represents the log2 HI titer difference for an individual 
antiserum between a representative virus and a mutant with 155TY or 155YT, 
or between mutants with 155HT and 155HY (indicated as 155TY for SI87, 
BE89, BE92, WU95, and SY97). Color coding indicates the corresponding 
antigenic clusters for the strains used to raise the antisera (Fig 1A). The 2-fold 
difference in HI titer considered to be the error of the HI assay is indicated by 
the dashed horizontal line. (B) HI titer differences between viruses with wildtype 
HA and 145K or 145N mutants. Symbols as in panel A. (C) HI titer differences 
between cluster representatives, 145K mutants, and cluster-transition mutants. 
Each symbol represents the log2 HI titer difference for an individual antiserum 
between viruses with wildtype and 145K mutant HA or between the wildtype 
and cluster-transition mutant virus. For the analysis in panel C only antisera to 
strains from the same or preceding antigenic clusters as the representative 
virus were included. Color coding as in panel A. Shapes indicate the individual 
antisera used for this analysis. HI data are available from Table S2. 
 
FIG 3 Cartoon representation of the A/Aichi/2/68 RBS area. Positions 155 and 
145 are indicated in blue and red, respectively. Positions 195Y and 153W, 
which are conserved among influenza A virus subtypes (14, 15), are indicated 
in pink.  
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